{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2013"],"condition":["Colorectal Cancer"],"disease":["Colorectal Cancer"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2629287"],"location":["Japan"],"study_start_month":["12"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Clinical pharmacology study to evaluate the pharmacokinetics, safety and efficacy of multi-targetted tyrosine kinase inhibitor regorafenib in Japanese patients with advanced colorectal cancer.","description":"Primary outcome(s): pharmacokinetics, progression free survival, response rate, adverse event,","dates":{"creation":"2013-12-15"},"accession":"2629287","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000013939"]}}